Related Experiment Video
Updated: Aug 16, 2025

04:25
Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
Published on: October 28, 2021
9.6K
Improving Osteosarcoma Treatment: Comparative Oncology in Action
Lidia Tarone1, Katia Mareschi2,3, Elisa Tirtei2,3
1Molecular Biotechnology Center "Guido Tarone", Department of Molecular Biotechnology and Health Sciences, University of Torino, Via Nizza 52, 10126 Torino, Italy.
Life (Basel, Switzerland)
|December 23, 2022
Summary
Osteosarcoma (OSA) research benefits from studying pet dogs, offering a valuable model for developing new therapies. Comparative oncology highlights canine osteosarcoma
Area of Science:
- Comparative oncology
- Veterinary medicine
- Translational cancer research
Background:
- Osteosarcoma (OSA) is a common pediatric bone cancer with poor outcomes for recurrent/metastatic disease.
- Current therapies offer limited improvement for advanced OSA, necessitating novel treatment strategies.
- Pre-clinical mouse models have limitations in translating findings to human clinical success.
Purpose of the Study:
- To review recent veterinary research on novel therapeutic strategies for osteosarcoma.
- To highlight the value of pet dogs as a comparative oncology model for OSA.
- To focus on immune-based combinatorial approaches for canine and human OSA patients.
Main Methods:
- Review of recent veterinary investigations on osteosarcoma treatment.
- Analysis of comparative oncology principles using pet dogs as a model.
- Focus on immune-based and combinatorial therapeutic strategies.
Main Results:
- Pet dogs develop spontaneous osteosarcoma with biological and clinical similarities to human tumors.
- Canine osteosarcoma models exhibit metastatic behavior and resistance to conventional therapies, mirroring human disease.
- Veterinary studies are increasingly recognized for their translational power in OSA research.
Conclusions:
- Canine osteosarcoma models are crucial for advancing the field due to their immune-competence and disease similarity to humans.
- Novel combinatorial and immune-based therapies studied in dogs hold promise for both veterinary and human OSA patients.
- Comparative oncology offers a valuable platform for addressing unmet clinical needs in osteosarcoma treatment.
Related Concept Videos
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Cancer Survival Analysis
413
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
413

